Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ГБУЗ «Московский научно-практический центр дерматовенерологии и косметологии» Департамента здравоохранения г. Москвы. 119071, Россия, Москва, Ленинский пр-т, д. 17; 2ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России (Сеченовский Университет). 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2; 3ФГБНУ «Научный центр психического здоровья». 115522, Россия, Москва, Каширское ш., 34
Список исп. литературыСкрыть список 1. Гаджигороева А.Г. Клиническая трихология. М.: Практическая медицина, 2014. / Gadzhigoroeva A.G. Klinicheskaia trikhologiia. M.: Prakticheskaia meditsina, 2014. [in Russian] 2. Смулевич А.Б., Иванов О.Л., Львов А.Н., Дороженок И.Ю. Психодерматология: современное состояние проблемы. Журн. неврологии и психиатрии. 2004; 11: 4–14. / Smulevich A.B., Ivanov O.L., L'vov A.N., Dorozhenok I.Iu. Psikhodermatologiia: sovremennoe sostoianie problemy. Zhurn. nevrologii i psikhiatrii. 2004; 11: 4–14. [in Russian] 3. Koblentzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983; 119 (6): 501–12. 4. Van Moffaert M. Psychodermatology: an overview. Psychother Psychosom 1992; 58 (3–4): 125–36. 5. Panconesi E, Hautmann G. Psychophysiology of stress in Dermatology: The psychobiologic pattern of psychosomatics. Dermatol Clin 1996; 14 (3): 399–421. 6. Garcia-Hernandez MJ, Ruiz-Doblado S, Rodriguez-Pichardo A. Alopecia Areata, Stress and Psychiatric Disorders: A Review. J Dermatol 1999; 26: 625–32. 7. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alopecia areata: Psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42 (6): 434–7. 8. Colaianni G, Poot F. How to Reach Emotions with Psychosomatic Patients: A Case Report. Acta Derm Venereol 2016; 96 (217): 109–12. 9. Merikangas KR, He JP, Burstein M et al. Lifetime Prevalence of Mental Disorders in US Adolescents: Results from the National Comorbidity Study-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010; 49 (10): 980–9. 10. Wittchen HU, Jacobi F, Rehm J et al. The size and burden of mental disorders and other disorders of the brain in Europe. Eur Neuropsychopharmacol 2011; 21 (9): 655–79. 11. Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994; 33 (12): 849–50. 12. Colon EA, Popkin MK, Callies AL et al. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compreh Psychiatry 1991; 32: 245–51. 13. Abedini H, Farshi S, Mirabzadeh A, Keshavarz S. Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat 2014; 25 (2): 153–5. 14. Cordan Yazici A, Basterzi A, Tot Acar S et al. Alopecia areata and alexithymia. Turk Psikiyatri Derg 2006; 17 (2): 101–6. 15. Güleç AT, Tanriverdi N, Dürü C et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004; 43 (5): 352–6. 16. Tucker Р. Bald Is Beautiful? The Psychosocial Impact of Alopecia Areata. J Health Psychology 2009; 14 (1): 142–51. 17. Астафьева Н.Г., Еремина М.Г. Профессиональная и социальная активность как важные характеристики качества жизни трудоспособных лиц с заболеваниями кожи. Социология медицины. 2014; 1. / Astaf'eva N.G., Eremina M.G. Professional'naia i sotsial'naia aktivnost' kak vazhnye kharakteristiki kachestva zhizni trudosposobnykh lits s zabolevaniiami kozhi. Sotsiologiia meditsiny. 2014; 1. [in Russian] 18. Новик А.А., Ионова Т.И. Исследование качества жизни в медицине. Учебное пособие для вузов. М., 2004. / Novik A.A., Ionova T.I. Issledovanie kachestva zhizni v meditsine. Uchebnoe posobie dlia vuzov. M., 2004. [in Russian] 19. Вассерман Л.И., Трифонова Е.А., Федорова В.Л. Внутренняя картина болезни в структуре качества жизни у больных с соматической патологией. Сибирский психологический журн. 2008; 27: 67–71. / Vasserman L.I., Trifonova E.A., Fedorova V.L. Vnutrenniaia kartina bolezni v strukture kachestva zhizni u bol'nykh s somaticheskoi patologiei. Sibirskii psikhologicheskii zhurn. 2008; 27: 67–71. [in Russian] 20. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001; 15: 137–9. 21. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–6. 22. Zhuang XS, Zheng YY, Xu JJ, Fan WX. Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients. Exp Ther Med 2013; 6 (2): 542–6. 23. Hahn HB, Melfi CA, Chuang TY et al. Use of the dermatology life quality index (DLQI) in a midwestern US urban clinic. J Am Acad Dermatol 2001; 45 (1): 44–8. 24. Katoulis AC, Christodoulou C, Liakou AI et al. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges 2015; 13 (2): 137–42. 25. Shi Q, Duvic M, Osei JS et al. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc 2013; 16 (1): S49–50. 26. Грищенко Ю.В. Оптимизация диагностики и патогенетической терапии андрогенетической алопеции у женщин. Автореф. дис. … канд. мед. наук. М., 2011. / Grishchenko Iu.V. Optimizatsiia diagnostiki i patogeneticheskoi terapii androgeneticheskoi alopetsii u zhenshchin. Avtoref. dis. … kand. med. nauk. M., 2011. [in Russian] 27. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol 2009; 160 (5): 1034–9. 28. Reid EE, Haley AC, Borovicka JH et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol 2012; 66 (3): e97–102. 29. Tabolli S, Sampogna F, di Pietro C et al. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Am J Clin Dermatol 2013; 14 (2): 139–45. 30. Chiang YZ, Bundy C, Griffiths CE et al. The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia Br J Dermatol 2015; 172 (1): 130–7. 31. Trüeb RM. The Difficult Hair Loss Patient. Guide to Successful Management of Hair Loss and Related Conditions. Cham, Springer International Publishing Switzerland, 2015. 32. Leventhal H, Meyer D, Nerenz DR. The common sense representation of illness danger. In: Contributions to Medical Psychology (Rachman S, ed.). Vol. 2. Oxford: Pergamon Press, 1980; p. 7–30. 33. Lau RR, Hartman KA. Common sense representations of common illnesses. Health Psychol 1983; 2: 167–86. 34. Leventhal H, Nerenz D, Steele D. Illness representations and coping with health threats. In: Handbook of Psychology and Health: Social Psychological Aspects of Health (Baum A, Taylor S, Singer J, eds). Vol. 4. Hillsdale, NJ: Erlbaum, 1984; p. 219–52. 35. Picardi A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143 (5): 983–91. 36. Alfonso M, Richter-Appelt H, Tosti A et al. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin 2005; 21 (11): 1829–36. 37. Camacho FM, García-Hernández M. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 2002; 16 (5): 476–80. 38. Budd D, Himmelberger D, Rhodes T et al. The effects of hair loss in European men: a survey in four countries. Eur J Dermatol 2000; 10 (2): 122–7. 39. Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26 (6): 926–31. 40. Cash TF. The psychological consequences of androgenetic alopecia: A review of the research literature. Br J Dermatol 1999; 141 (3): 398–405. 41. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993; 29 (4): 568–75. 42. Khoshdel A, Shekari A, Paydary K, Shekari A. Alopecia Areata: The Role of Stressful Events and an Estimate of Lifetime Risk in First-Degree Relatives. J Arch Mil Med Inpress (Inpress): e36377. 43. Hunt N, McHale S. Clinical review: The psychological impact of alopecia. BMJ 2005a; 331 (7522): 951–3. 44. Girman CJ, Hartmaier S, Roberts J et al. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med 1999; 8 (8): 1091–5. 45. Liakopoulou M, Alifieraki T, Katideniou A et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997; 36 (5): 678–84. 46. Van der Donk J, Passchier J, Knegt-Junk C et al. Psychological characteristics of women with androgenetic alopecia: a controlled study. Br J Dermatol 1991; 125: 248–52. 47. Baghestani S, Zare S, Seddigh SH. Severity of Depression and Anxiety in Patients with Alopecia Areata in Bandar Abbas, Iran. Dermatol Reports 2015; 7 (3): 6063. 48. Rafique R, Hunt N. Experiences and coping behaviours of adolescents in Pakistan with alopecia areata: an interpretative phenomenological analysis. Int J Qual Stud Health Well-being 2015; 10: 26039. 49. DeMuro-Mercon C, Rhodes T, Girman CJ, Vatten L. Male-pattern hair loss in Norwegian men: a community-based study. Dermatology 2000; 200 (3): 219–22. 50. Girman CJ, Rhodes T, Lilly FR et al. Effects of self-perceived hair loss in a community sample of men. Dermatology 1998; 197 (3): 223–9. 51. Wells PA, Willmoth T, Russell RJ. Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 1995; 86 (Pt 3): 337–44. 52. Wrosch C, Freund A. Self-regulation of normative and non-normative developmental challenges. Hum Development 2001; 44: 264–83. 53. Kranz D. Young men’s coping with androgenetic alopecia: Acceptance counts when hair gets thinner. Body Image 2011; 8 (4): 343–8. 54. Schmitt JV, Ribeiro CF, Souza FH et al. Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. An Bras Dermatol 2012; 87 (3): 412–7. 55. Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore – a study of 219 Asians. Int J Dermatol 2002; 41 (11): 748. 56. Смулевич А.Б. и др. Психосоматические расстройства в клинической практике. М.: МЕДпресс-информ, 2016; с. 776. / Smulevich A.B. i dr. Psikhosomaticheskie rasstroistva v klinicheskoi praktike. M.: MEDpress-inform, 2016; s. 776. [in Russian] 57. Львов А.Н. Дерматозы, коморбидные с психическими расстройствами: классификация, клиника, терапия и профилактика. Автореф. дис. … д-ра мед. наук. М., 2006. / L'vov A.N. Dermatozy, komorbidnye s psikhicheskimi rasstroistvami: klassifikatsiia, klinika, terapiia i profilaktika. Avtoref. dis. … d-ra med. nauk. M., 2006. [in Russian] 58. Смулевич А.Б., Львов А.Н. К проблеме классификации психических расстройств в дерматологии. Психические расстройства в общей медицине. 2008; 1: 22–5. / Smulevich A.B., L'vov A.N. K probleme klassifikatsii psikhicheskikh rasstroistv v dermatologii. Mental Disorders in General Medicine. 2008; 1: 22–5. [in Russian] 59. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996; 34: 1030–46. 60. Koo JYM, Lee CS. Psychocutaneous Medicine; New York: Marcel Dekker, Inc. 2003; p. 153–68. 61. Trüeb RM, Gieler U. Psychocutaneous disorders of hair and scalp. In: Blume-Peytavi U, Tosti A, Whiting DA, Trüeb RM (eds.) Hair Growth and Disorders, Springer Berlin Heidelberg 2008; p. 407–26. 62. Harth W, Blume-Peytavi U. Psychotrichology: psychosomatic aspects of hair diseases. J Dtsch Dermatol Ges 2013; 11 (2): 125–35. 63. Grahovac T, Ruzić K, Sepić-Grahovac D et al. Depressive disorder and alopecia. Psychiatr Danub 2010; 22 (2): 293–5. 64. Terashima Y, Ichikawa T, Suzuki T, Koizumi J. An adult case of psychogenic alopecia universalis. Jpn J Psychiatry Neurol 1989; 43 (4): 585–9. 65. Picardi A, Pasquini P, Cattaruzza MS et al. Psychosomatic factors in first-onset alopecia areata. Psychosomatics 2003; 44 (5): 374–81. 66. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21 (7): 921–8. 67. Brajac I, Tkalcic M, Dragojević DM, Gruber F. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol 2003; 30: 871–8. 68. Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: A psychodermatologic study. Acta Derm Venereol 1997; 77 (4): 296–8. 69. Matzer F, Egger JW, Kopera D. Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol 2011; 91 (3): 318. 70. Асриян Я.И. Оптимизация диагностики и патогенетической терапии гнездной алопеции. Автореф. дис. … канд. мед. наук. М., 2010. / Asriian Ia.I. Optimizatsiia diagnostiki i patogeneticheskoi terapii gnezdnoi alopetsii. Avtoref. dis. … kand. med. nauk. M., 2010. [in Russian] 71. Elkin TD, Hilker KA, Drabman RS. Anxiety and psychosocial concerns in alopecia areata: a case study. Clin Case Stud 2006; 5: 103–11. 72. Wygledowska-Kania M, Bogdanowski T. Psychic factors in case histories of patients with alopecia areata – preliminary report. Psychiatr Pol 1996; 30: 669–76. 73. Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients with alopecia areata about their disease. BMC Dermatol 2005; 5: 1. 74. Van der Steen P, Boezeman J, Duller P, Happle R. Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol 1992; 72 (4): 279–80. 75. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004; 123 (3): 455–7. 76. York J, Nicholson T, Minors P, Duncan DF. Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 1998; 82 (3 Pt 1): 1044–6. 77. Arck PC, Handjiski B, Hagen E et al. Indications for a "brain-hair follicle axis (BHA)": Inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001; 15 (13): 2536–8. 78. Arck PC, Handjiski B, Peters EM et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003; 162 (3): 803–14. 79. Paus R. Stress, hair growth control and the neuro-endocrine immune connection. Allergo J 2000; 9: 611–20. 80. Paus R, Arck P. Neuroendocrine perspectives in alopecia areata: does stress play a role. J Invest Dermatol 2009; 129 (6): 1324–6. 81. Peters EMJ, Handjiski B, Kuhlmann A et al. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004; 165 (1): 259–71. 82. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999; 20 (12): 485–90. 83. Галимов Р.К. Динамика тревожно-депрессивных расстройств в процессе лечения методом гипнотерапии больных, страдающих различными формами очаговой алопеции. Автореф. дис. … канд. мед. наук. М., 2011. / Galimov R.K. Dinamika trevozhno-depressivnykh rasstroistv v protsesse lecheniia metodom gipnoterapii bol'nykh, stradaiushchikh razlichnymi formami ochagovoi alopetsii. Avtoref. dis. … kand. med. nauk. M., 2011. [in Russian] 84. Kökçam I, Akyar N, Saral Y, Oğuzhanoğlu NK. Psychosomatic symptoms in patients with alopecia areata and vitiligo. Turk J Med Sci 1999; 29: 471–3. 85. Karia SB, De Sousa A, Shah N et al. Psychiatric morbidity and quality of life in skin diseases: A comparison of alopecia areata and psoriasis. Ind Psychiatry J 2015; 24 (2): 125–8. 86. Fossati A, Rinaldi F, Maestroni L et al. Trichologic consultation and personality disorders. G Ital Derm Venerol 1993; 128: 101–8. 87. Maffei C, Fossati A, Rinaldi F, Riva E. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 1994; 130 (7): 868–72. 88. Смулевич А.Б. Психические расстройства в клинической практике. Под ред. А.Б.Смулевича. М.: МЕДпресс-информ, 2011. / Smulevich A.B. Psikhicheskie rasstroistva v klinicheskoi praktike. Pod red. A.B.Smulevicha. M.: MEDpress-inform, 2011. [in Russian] 89. Смулевич А.Б., Фильц А.О., Лебедева М.О. К проблеме алгопатических состояний. В кн.: Ипохондрия и соматоформные расстройства. Под ред. А.Б.Смулевича. М., 1992; с. 40–59. / Smulevich A.B., Fil'ts A.O., Lebedeva M.O. K probleme algopaticheskikh sostoianii. V kn.: Ipokhondriia i somatoformnye rasstroistva. Pod red. A.B.Smulevicha. M., 1992; s. 40–59. [in Russian] 90. Hunt N, McHale S. Reported experiences of persons with alopecia areata. J Loss Trauma 2005b; 10: 33–50. 91. Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol 2001; 19 (2): 161–6. 92. Cash TF, Santos MT, Williams EF. Coping with body-image threats and challenges: Validation of the Body Image Coping Strategies Inventory. J Psychosom Res 2005; 58 (2): 190–9. 93. Ghajarzadeh M, Ghiasi M, Kheirkhah S. Depression and quality of life in Iranian patients with Alopecia Areata. Iran J Dermatol 2011; 14: 140–3. 94. Brosig B, Kupfer J, Niemeier V, Gieler U. The "Dorian Gray Syndrome": psychodynamic need for hair growth restorers and other "fountains of youth." Int J Clin Pharmacol Ther 2001; 39 (7): 279–83. 95. Castle DJ, Phillips KA, Dufresne RG Jr. Body dysmorphic disorder and cosmetic dermatology: more than skin deep. J Cosmet Dermatol 2004; 3 (2): 99–103. 96. Schilder P. The Image and Appearance of the Human Body. New York: International Universities Press, 1950. 97. Cash T, Smolak L. Body Image (2nd ed.). A handbook of science, practice and prevention. NY: Guilford Press, 2012. 98. Ladee G. Hypochondrical syndromes. Amsterdam, 1966. 99. Nardi AE. Psychological impact of alopecia: alopecia may lead to social anxiety. BMJ 2005; 331 (7524): 1084. 100. Матюшенко Е.Н. Дисморфофобия в дерматологической практике. Психические расстройства в общей медицине. 2011; 3–4: 11–17. / Matiushenko E.N. Dismorfofobiia v dermatologicheskoi praktike. Mental Disorders in General Medicine. 2011; 3–4: 11–17. [in Russian] 101. Beck AT. Depression: clinical, experimental, and theoretical aspects. New York: Staples Press, 1969; p. 370. 102. Дороженок И.Ю., Матюшенко Е.Н., Олисова О.Ю. Дисморфофобия у дерматологических больных с фациальной локализацией процесса. Рос. журн. кожных и венерических болезней. 2014; 1: 42–7. / Dorozhenok I.Iu., Matiushenko E.N., Olisova O.Iu. Dismorfofobiia u dermatologicheskikh bol'nykh s fatsial'noi lokalizatsiei protsessa. Ros. zhurn. kozhnykh i venericheskikh boleznei. 2014; 1: 42–7. [in Russian] 103. Rahman SZ, Gupta V, Sukhlecha A, Khunte Y. Lifestyle drugs: Concept and impact on society. Indian J Pharm Sci 2010; 72 (4): 409–13. 104. Foley J, Breslau L. A new syndrome of delusional misidentification. Ann Neurology 1982; 12: 76. 105. De Pauw KW. Delusional Misidentification: A plea for an agreed terminology and classification. Psychopathology 1994; 27 (3–5): 123–9. 106. Калинин В.В. Бредовые синдромы ложного узнавания: спорные вопросы классификации, феноменологии, прогноза и терапии. Психиатрия и психофармакотерапия им. П.Б.Ганнушкина. 2001; 6: 192–8. / Kalinin V.V. Bredovye sindromy lozhnogo uznavaniia: spornye voprosy klassifikatsii, fenomenologii, prognoza i terapii. Psychiatry and Psychopharmacotherapy. 2001; 6: 192–8. [in Russian] 107. Marmar CR, Weiss DS, Schlenger WE et al. Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. Am J Psychiatry 1994; 151 (6): 902–7. 108. Fullerton CS, Ursano RJ, Epstein RS et al. Peritraumatic dissociation following motor vehicle accidents: relationship to prior trauma and prior major depression. J Nerv Ment Dis 2000; 188 (5): 267–72. 109. Boelen PA, Keijsers L, van den Hout MA. Peritraumatic dissociation after loss: latent structure and associations with psychopathology. J Nerv Ment Dis 2012; 200 (4): 362–4. 110. Hunt N, McHale S. Coping with alopecia. London: Sheldon Press, 2004. 111. Brown RJ. Different types of "dissociation" have different psychological mechanisms. J Trauma Dis 2006; 7 (4): 7–28. 112. Spitzer C, Barnow S, Freyberger HJ, Grabe HJ. Recent developments in the theory of dissociation. World Psychiatry 2006; 5 (2): 82–6. 113. Holmes EA, Brown RJ, Mansell W et al. Are there two qualitatively distinct forms of dissociation? A review and some clinical implications. Clin Psychol Rev 2005; 25 (1): 1–23. 114. Смулевич А.Б., Иванов С.В., Мясникова Л.К. и др. Диссоциативные расстройства в онкологии: психопатология, аспекты коморбидности с расстройствами личности. Психические расстройства в общей медицине. 2014; 3–4: 4–14. / Smulevich A.B., Ivanov S.V., Miasnikova L.K. i dr. Dissotsiativnye rasstroistva v onkologii: psikhopatologiia, aspekty komorbidnosti s rasstroistvami lichnosti. Mental Disorders in General Medicine. 2014; 3–4: 4–14. [in Russian] 115. Германова К.Н., Читлова В.В. Диссоциативные расстройства в структуре психогений у больных шизофренией и расстройствами шизофренического спектра. Психиатрия. 2014; 4 (64): 5–10. / Germanova K.N., Chitlova V.V. Dissotsiativnye rasstroistva v strukture psikhogenii u bol'nykh shizofreniei i rasstroistvami shizofrenicheskogo spektra. Psikhiatriia. 2014; 4 (64): 5–10. [in Russian] 116. Самушия М.А. Психические расстройства у больных злокачественными новообразованиями органов женской репродуктивной системы (клиника, эпидемиология, терапия). Автореф. дис. … д-ра мед. наук. М., 2015. / Samushiia M.A. Psikhicheskie rasstroistva u bol'nykh zlokachestvennymi novoobrazovaniiami organov zhenskoi reproduktivnoi sistemy (klinika, epidemiologiia, terapiia). Avtoref. dis. … d-ra med. nauk. M., 2015. [in Russian] 117. Петелин Д.С., Лукин А.В. Феномен откладывания в онкологии (обзор литературы). Психические расстройства в общей медицине. 2015; 2–3: 40–53. / Petelin D.S., Lukin A.V. Fenomen otkladyvaniia v onkologii (obzor literatury). Mental Disorders in General Medicine. 2015; 2–3: 40–53. [in Russian] 118. Sulzberger MB, Witten VH, Kopf AW. Diffuse alopecia in women. Its unexplained apparent increase in incidence. Arch Dermatol 1960; 81: 556–60. 119. Rebora A. Trichodynia: a review of the literature. Int J Dermatol 2016; 55 (4): 382–4. 120. Hoss D, Segal S. Scalp dysesthesia. Arch Dermatol 1998; 134: 327–30. 121. Kivanc-Altunay I, Savas C, Gokdemir G et al. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 2003; 42: 691–3. 122. Willimann B, Trüeb RM. Hair pain (trichodynia): frequency and relationship to hair loss and patient gender. Dermatology 2002; 205 (4): 374–7. 123. Романов Д.В., Финн В.К., Фабрикантова Е.Ф. и др. Интеллектуальная система типа ДСМ для автоматизированной поддержки исследования коэнестезиопатических расстройств (зуда) в дерматологической практике: методология и некоторые результаты. Психические расстройства в общей медицине. 2015; 4: 30–9. / Romanov D.V., Finn V.K., Fabrikantova E.F. i dr. Intellektual'naia sistema tipa DSM dlia avtomatizirovannoi podderzhki issledovaniia koenesteziopaticheskikh rasstroistv (zuda) v dermatologicheskoi praktike: metodologiia i nekotorye rezul'taty. Mental Disorders in General Medicine. 2015; 4: 30–9. [in Russian] 124. Tosti A, Misciali C, Piraccini BM et al. Drug-induced hair-loss and hair growth. Drug Saf 1994; 10: 310–7. 125. Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin 2007; 25 (2): 223–31, vii. 126. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983; 143: 42–50. 127. Orwin A. Hair loss following lithium therapy. Br J Dermatol 1983; 108 (4): 503–4. 128. Pillans PL, Woods DJ. Drug-associated alopecia. Int J Dermatol 1995; 34 (3): 149–58. 129. McKinney PA, Finkenbine RD, deVane CL. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 1996; 8 (3): 183–5. 130. Mercke Y, Sheng H, Khan T et al. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12: 35–42. 131. Tomita T, Goto H, Yoshida T et al. Dose-dependent valproate-induced alopecia in patients with mental disorders. Indian J Pharmacol 2015; 47 (6): 690–2. 132. Lampl Y, Gillad R, Savira-Pinchas I, Barak T. Hair loss – an adverse reaction to treatment with vigabatrin. Acta Ther 1996; 22: 51–5. 133. Picard C, Jonville-Bera AP, Billard C, Autret E. Alopecia associated with gabapentin: first case. Ann Pharmacother 1997; 31 (10): 1260. 134. Wheatley D. Hair loss with antidepressants. Hum Psychopharmacol 1993; 8: 439–41. 135. Baral J, Deakins S. Imipramine-induced alopecia areata-like lesions. Int J Dermatol 1987; 26 (3): 198. 136. Krasowska D, Szymanek M, Schwartz RA, Myśliński W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol 2007; 56 (5): 848–53. 137. Guzmán-Sánchez D, Asz-Sigall D. Alopecias due to drugs and other skin and systemic disorders. Curr Probl Dermatol 2015; 47: 97–106. 138. Kıvrak Y, Yağcı İ, Üstündağ MF, Özcan H. Diffuse Hair Loss Induced by Sertraline Use. Case Rep Psychiatry 2015; 2015: 703453. 139. Kubota T, Ishikura T, Jibiki I. Alopecia areata associated with haloperidol. Jpn J Psychiatry Neurol 1994; 48 (3): 579–81. 140. Physicians’ Desk Reference, 53rd ed. Montvale, NJ: Medical Economics, 1999. 141. Leung M, Wrixon K, Remick RA. Olanzapine-induced hair loss. Can J Psychiatry 2002; 47 (9): 891–2. 142. McLean RM, Harrison-Woolrych M. Alopecia associated with quetiapine. Int Clin Psychopharmacol 2007; 22 (2): 117–9. 143. Bhattacharya A, Roy D, Hazarika S et al. Alopecia areata associated with haloperidol decanoate long-acting injection. Aust N Z J Psychiatry 2012; 46 (1): 69. 144. Cipriani R, Perini GI, Rampinelli S. Paroxetine in alopecia areata. Int J Dermatol 2001; 40: 600–1. 145. Ricciardi A, Ruberto A, García-Hernández MJ et al. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment. J Eur Acad Dermatol Venereol 2006; 20 (8): 1000–1. 146. Perini G, Zara M, Cipriani R et al. Placebo-Controlled Study Psychother Psychosom 1994; 61 (3–4): 195–8.